跳至主要内容
临床试验/CTRI/2023/12/060907
CTRI/2023/12/060907尚未招募未知

Comparative efficacy of intralesional 5-Fluorouracil and intralesional MMR vaccine in verruca vulgaris - NI

Department of Dermatology0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
未知
状态
尚未招募

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • 1. All consecutive patients having lesions of verruca vulgaris.
  • 2. Patients between the ages of 14-60 years.

排除标准

  • 1. Pregnant or females planning for pregnancy or lactating mothers.
  • 2. Immunocompromised individuals including HIV-AIDS.
  • 3. Patients with known hypersensitivity to MMR vaccine or components of the vaccine (e.g. neomycin, gelatin) or 5-FU.
  • 4. Patients having any significant systemic illness.
  • 5. Patients having taken any vaccine in the last 4 weeks.

研究者

相似试验